GLP-1s are quietly rewiring demand across categories, shrinking baskets, accelerating wardrobe churn, and pushing more consumers into temperature-sensitive aesthetic treatments, reveals Yahyah Pandor, VP & GM – MENAT, Blue Yonder
10 June, 2026
The rise of self-prescribed GLP-1 use is emerging as a significant public health issue, particularly as patients attempt to manage dosing, duration, and discontinuation independently, says Dr. Ihsan Almarzooqi, co-founder and managing director of Metabolic
09 May, 2026
1
2
3
4